Khaled Musallam

Khaled Musallam, MD, PhD has held various roles and positions throughout their career. In 2021, they became the Founding Director of the Center for Research on Rare Blood Disorders (CR-RBD) at Burjeel Holdings, where they also serve as the Group Chief Research Officer. Additionally, since 2022, Dr. Musallam has been an Adjunct Clinical Professor at Khalifa University.

Prior to their current positions, Dr. Musallam founded and served as Managing Director of Evida Medical DMCC starting in 2014. Khaled has also held roles at AMICULUM MENA, including Agency Lead and Global Medical Lead starting in 2019 and 2016 respectively. Dr. Musallam is a Co-Founder and Consultant at Evida since 2017.

Dr. Musallam also served as the President of the International Network of Hematology starting in 2016. Before that, they worked at Novartis Pharma AG as the Clinical Lead for Oncology Global Development & Global Medical Affairs from 2013 to 2014.

Earlier in their career, Dr. Musallam held postdoctoral research fellow positions at Università degli Studi di Milano from 2011 to 2012 and at American University of Beirut from 2009 to 2011.

Khaled Musallam, MD, PhD obtained a Bachelor of Science (BS) with Distinction in Biology from the American University of Beirut in 2004. Khaled then pursued further education at the same university and received a Doctor of Medicine (MD) degree in 2009. After that, they attended Leiden University Medical Center in Leiden, the Netherlands, where they completed a Doctor of Philosophy (PhD) in an undisclosed field of study in 2012.